FDA Inspection 1027076 — Zhejiang Hisun Pharmaceutical Co., Ltd.

Zhejiang Hisun Pharmaceutical Co., Ltd. — FEI 3007719313

The FDA completed an inspection of Zhejiang Hisun Pharmaceutical Co., Ltd. on August 11, 2017 in Taizhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 11, 2017
Fiscal Year
2017
Product Type
Veterinary
Project Area
Pre-Approval Eval. of Animal Drugs and Food Additives
Location
Taizhou (China)